Everolimus for postmenopausal women with advanced breast cancer: Updated results of the BOLERO-2 phase III trial.

被引：0

作者：

Piccart-Gebhart, Martine J.

Noguchi, Shinzaburo

Pritchard, Kathleen I.

Burris, Howard A.

Rugo, Hope S.

Gnant, Michael

Hortobagyi, Gabriel N.

Melichar, Bohuslav

Petrakova, Katarina

Arena, Francis P.

Xu, Cindy

Cahana, Ayelet

Taran, Tanya

Sahmoud, Tarek

Lebwohl, David Edward

Campone, Mario

Baselga, Jose

机构：

[1] Univ Libre Brussels, Inst Jules Bordet, Brussels, Belgium

[2] Osaka Univ, Dept Breast & Endocrine Surg, Osaka, Japan

[3] Univ Toronto, Sunnybrook Odette Canc Ctr, Toronto, ON, Canada

[4] Sarah Cannon Res Inst, Nashville, TN USA

[5] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA

[6] Med Univ Vienna, Dept Surg, Ctr Comprehens Canc, Vienna, Austria

[7] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[8] Palacki Univ, Sch Med, Olomuc, Czech Republic

[9] Teaching Hosp, Olomuc, Czech Republic

[10] Masaryk Mem Canc Inst, Brno, Czech Republic

[11] Arena Oncol Associates, Lake Success, NY USA

[12] Novartis Pharmaceut, E Hanover, NJ USA

[13] Novartis Pharmaceut, Florham Pk, NJ USA

[14] Ctr Rech Cancerol, Inst Cancerol Ouest Rene Gauducheau, St Herblain, France

[15] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA

[16] Harvard Univ, Sch Med, Boston, MA USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

559

引用

页数：1